eMedicine Specialties > Ophthalmology > Ophthalmology for the General Practitioner

Myasthenia Gravis: Follow-up

Author: Shady Awwad, MD, Staff Physician, Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas
Coauthor(s): Riad Ma'luf, MD, Head, Division of Oculoplastics, Department of Ophthalmology, Clinical Assistant Professor, American University of Beirut Medical Center; Nicolas Hamush, MD, Consulting Staff, Department of Ophthalmology, Eye & Ear Hospital International, Naccache, Lebanon
Contributor Information and Disclosures

Updated: Jul 13, 2007

Follow-up

Further Inpatient Care

  • Intubation and intensive care unit transfer usually are reserved for patients in myasthenic crisis with respiratory failure. Plasmapheresis or IV Ig also will be needed.

Further Outpatient Care

  • Follow-up care is conducted mainly by the neurologist, who would orchestrate the treatment. The ophthalmologist is consulted accordingly.

Inpatient & Outpatient Medications

Complications

  • Systemically, myasthenic crisis is the most dreadful complication. Aspiration pneumonia also may occur due to the poor oropharyngeal muscle function. Cholinergic crisis may follow excessive treatment with cholinesterase inhibitors.
  • Ophthalmologically, a common complication is cataract formation due to chronic steroid intake.

Prognosis

  • Approximately 15-17% of patients will remain having strictly ocular symptoms over a mean follow-up period of 17 years, as determined in one study. Those patients are referred to as having ocular MG. The rest develop a generalized weakness and are referred to as having generalized MG.
  • Some evidence shows that steroids or azathioprine might prevent the conversion to generalized MG in 75% of patients with ocular MG.
  • Bever and coworkers reported that 82% of patients who later developed generalized weakness did so in the first 2 years after diagnosis.16 Hence, patients who keep having strictly ocular symptoms for 3 or more years are unlikely to revert to the generalized aspect of the disease.
  • The juvenile form of the disease usually has a much more favorable prognosis than the adult one, with a better chance of spontaneous remission.

Patient Education

  • Patients should be instructed to immediately report any noticeable decrease in their respiratory function.
  • It should be made clear to patients that some common medications, such as aminoglycosides, penicillin, and ciprofloxacin, can exacerbate the symptoms. They should always consult their neurologist prior to starting any of the medications listed above.

Miscellaneous

Medicolegal Pitfalls

  • It is essential to rule out mass lesions compressing the cranial nerves in strictly ocular MG. A CT scan or MRI of the brain and orbit is indicated.
 


More on Myasthenia Gravis

Overview: Myasthenia Gravis
Differential Diagnoses & Workup: Myasthenia Gravis
Treatment & Medication: Myasthenia Gravis
Follow-up: Myasthenia Gravis
Multimedia: Myasthenia Gravis
References

References

  1. Qureshi AI, Choundry MA, Mohammad Y, Chua HC, Yahia AM, Ulatowski JA, et al. Respiratory failure as a first presentation of myasthenia gravis. Med Sci Monit. Dec 2004;10(12):CR684-689. [Medline].

  2. Cogan DG. Myasthenia gravis: A review of the disease and a description of lid twitch as a characteristic sign. Arch Ophthalmol. Aug 1965;74:217-21. [Medline].

  3. Van Stavern GP, Bhatt A, Haviland J, Black EH. A prospective study assessing the utility of Cogan's lid twitch sign in patients with isolated unilateral or bilateral ptosis. J Neurol Sci. May 15 2007;256(1-2):84-5. [Medline].

  4. Cooper J, Pollak GJ, Ciuffreda KJ, Kruger P, Feldman J. Accommodative and vergence findings in ocular myasthenia: a case analysis. J Neuroophthalmol. Mar 2000;20(1):5-11. [Medline].

  5. Padua L, Stalberg E, LoMonaco M, Evoli A, Batocchi A, Tonali P. SFEMG in ocular myasthenia gravis diagnosis. Clin Neurophysiol. Jul 2000;111(7):1203-7. [Medline].

  6. Phillips LH 2nd, Melnick PA. Diagnosis of myasthenia gravis in the 1990s. Semin Neurol. Mar 1990;10(1):62-9. [Medline].

  7. Toth L, Toth A, Dioszeghy P, Repassy G. Electronystagmographic analysis of optokinetic nystagmus for the evaluation of ocular symptoms in myasthenia gravis. Acta Otolaryngol. 1999;119(6):629-32. [Medline].

  8. Yang Q, Wei M, Sun F, Tian J, Chen X, Lu C. Open-loop and closed-loop optokinetic nystagmus (OKN) in myasthenia gravis and nonmyasthenic subjects. Exp Neurol. Nov 2000;166(1):166-72. [Medline].

  9. Movaghar M, Slavin ML. Effect of local heat versus ice on blepharoptosis resulting from ocular myasthenia. Ophthalmology. Dec 2000;107(12):2209-14. [Medline].

  10. Benatar M. A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord. Jul 2006;16(7):459-67. [Medline].

  11. Nieto IP, Robledo JP, Pajuelo MC, Montes JA, Giron JG, Alonso JG, et al. Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases. Ann Thorac Surg. Jun 1999;67(6):1568-71. [Medline].

  12. Acheson JF, Elston JS, Lee JP, Fells P. Extraocular muscle surgery in myasthenia gravis. Br J Ophthalmol. Apr 1991;75(4):232-5. [Medline].

  13. Davidson JL, Rosenbaum AL, McCall LC. Strabismus surgery in patients with myasthenia. J Pediatr Ophthalmol Strabismus. Sep-Oct 1993;30(5):292-5. [Medline].

  14. Bradley EA, Bartley GB, Chapman KL, Waller RR. Surgical correction of blepharoptosis in patients with myasthenia gravis. Ophthal Plast Reconstr Surg. Mar 2001;17(2):103-10. [Medline].

  15. Bernardini FP, de Conciliis C, Devoto MH. Frontalis suspension sling using a silicone rod in patients affected by myogenic blepharoptosis. Orbit. Sep 2002;21(3):195-8. [Medline].

  16. Bever CT Jr, Aquino AV, Penn AS, Lovelace RE, Rowland LP. Prognosis of ocular myasthenia. Ann Neurol. Nov 1983;14(5):516-9. [Medline].

  17. Barton JJ, Fouladvand M. Ocular aspects of myasthenia gravis. Semin Neurol. 2000;20(1):7-20. [Medline].

  18. Benatar M, Kaminski HJ. Evidence report: The medical treatment of ocular myasthenia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. Jun 12 2007;68(24):2144-9. Epub 2007 Apr 25. [Medline].

  19. Drachman DB. Myasthenia gravis. N Engl J Med. Jun 23 1994;330(25):1797-810. [Medline].

  20. Larner AJ, Thomas DJ. Can myasthenia gravis be diagnosed with the 'ice pack test'? A cautionary note. Postgrad Med J. Mar 2000;76(893):162-3. [Medline].

  21. Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med. Nov-Dec 1971;38(6):497-537. [Medline].

  22. Wang ZY, Diethelm-Okita B, Okita DK, Kaminski HJ, Howard JF, Conti-Fine BM. T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis. J Neuroimmunol. Aug 1 2000;108(1-2):29-39. [Medline].

  23. Wasserman BN, Chronister TE, Stark BI, Saran BR. Ocular myasthenia and nitrofurantoin. Am J Ophthalmol. Oct 2000;130(4):531-3. [Medline].

Further Reading

Keywords

MG, ocular myasthenia gravis, generalized myasthenia gravis, ocular MG, generalized MG, neuromuscular disorder

Contributor Information and Disclosures

Author

Shady Awwad, MD, Staff Physician, Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas
Shady Awwad, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, and American Society of Cataract and Refractive Surgery
Disclosure: Nothing to disclose.

Coauthor(s)

Riad Ma'luf, MD, Head, Division of Oculoplastics, Department of Ophthalmology, Clinical Assistant Professor, American University of Beirut Medical Center
Disclosure: Nothing to disclose.

Nicolas Hamush, MD, Consulting Staff, Department of Ophthalmology, Eye & Ear Hospital International, Naccache, Lebanon
Nicolas Hamush, MD is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Nothing to disclose.

Medical Editor

Kilbourn Gordon III, MD, FACEP, Urgent Care Physician, Primary Medical, Huntington Walk-In and Greenwich Convenient Medical Center
Kilbourn Gordon III, MD, FACEP is a member of the following medical societies: American Academy of Ophthalmology and Wilderness Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

J James Rowsey, MD, Former Director of Corneal Services, St Luke's Cataract and Laser Institute, Florida
J James Rowsey, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for the Advancement of Science, American Medical Association, Association for Research in Vision and Ophthalmology, Florida Medical Association, Pan-American Association of Ophthalmology, Sigma Xi, and Southern Medical Association
Disclosure: Nothing to disclose.

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.